NIHR EME Stage 2 application submitted
The full Stage 2 application (NIHR510996) for the GAP trial has been submitted to the NIHR Efficacy and Mechanism Evaluation Programme. We expect a decision later in 2026, with trial start-up activities planned for 2027.
